Company InformationFusion Genomics Corporation was founded on July 2013. The company is based in Burnaby. The number of employees in Fusion Genomics Corporation is less than 50. Fusion genomics develops highly sensitive and massively multiplex dna/rna sequencing based diagnostics for infectious diseases.
Funding & investorsFusion Genomics Corporation has received 2 rounds of venture funding. The total funding amount is around $1M.
Similar Companies [beta]
- Clene nanomedicine
- Prelude therapeutics
- Eliem therapeutics
- Maze therapeutics
- Adamis pharmaceuticals
Active Venture Investors
Fusion Genomics Corporation - Blog
- Fusion Genomics Clinically Validating NGS Test for Infectious Disease; Eyes 2020 FDA Submission
- Fusion Genomics Receives $1 Million from CQDM To Study ONETest RTI Assay
- Fusion Connects with China!
- Fusion is looking to hire a Postdoctoral Fellow
- Fusion is Hiring!
- Fusion Genomics Chosen for Ready-to-Rocket B.C. list
GenomeWeb just published this article in their latest issue. It highlights our collaboration with Toronto’s Sunnybrook Research Institute to clinically validate our ONETest Rapid product that assays infectious diseases. It goes on to feature our new Series A funding round. Any monies raised will go to support additional clinical studies to validate our syndromic ONETest … Continue reading Fusion Genomics Clinically Validating NGS Test for Infectious Disease; Eyes 2020 FDA Submission →
We are pleased to share the news that Fusion Genomics has received a $1 million award to conduct a study evaluating our comprehensive, novel ONETest PathoGenome assay for the detection of pathogens associated with respiratory tract infections (RTIs). Due in great part to limitations associated with current diagnostic tests, RTIs are a leading cause of … Continue reading Fusion Genomics Receives $1 Million from CQDM To Study ONETest RTI Assay →
C2 iBridge interview with Fusion’s Mohammad Qadir Fusion’s CSO, Dr Mohammad Qadir recently attended the Canada China Innovation & Investment Summit 2019 put together by C2CAN. Dr Qadir was recently interviewed in their September 2019 newsletter starting on page 6. As the key organizer of the summit, C2CAN is a collaborative platform between SFU VentureLabsⓇ, … Continue reading Fusion Connects with China! →
FUSION GENOMICS Corporation is a molecular diagnostic company that develops clinical assays using next-generation sequencing technologies to characterize infectious disease agents of clinical and global importance. We are looking to hire a full-time Postdoctoral Fellow to join our team in an exciting and highly dynamic start-up environment. FUSION GENOMICS is looking for a passionate, self driven, team player to join our … Continue reading Fusion is looking to hire a Postdoctoral Fellow →
Junior/Senior Computational Biologist Fusion Genomics is looking to hire a full-time Senior Computational Biologist to join our software development team in an exciting and highly dynamic start-up environment. The successful applicant will participate in developing, improving and maintaining bioinformatics tools that will advance our NGS assays. This will entail the analysis and interpretation of assay … Continue reading Fusion is Hiring! →